Net profit of Lincoln Pharmaceuticals rose 16.94% to Rs 27.68 crore in the quarter ended June 2025 as against Rs 23.67 crore during the previous quarter ended June 2024. Sales rose 4.61% to Rs 154.07 crore in the quarter ended June 2025 as against Rs 147.28 crore during the previous quarter ended June 2024.
| Particulars | Quarter Ended |
| Jun. 2025 | Jun. 2024 | % Var. |
| Sales | 154.07 | 147.28 | 5 |
| OPM % | 15.45 | 15.43 | - |
| PBDT | 38.87 | 32.70 | 19 |
| PBT | 35.39 | 29.48 | 20 |
| NP | 27.68 | 23.67 | 17 |